Saatja: Obon Roger <
[email protected]>
Saaja: Esindus EL juures üldaadress, Nominations
Teema: Estonia - 2021-03-01 - Nomination invitation for PRAC member and alternate
For the attention of HE Mr Aivo Orav,
Your Excellency,
Please find attached a letter from the Executive Director of the European Medicines Agency regarding the nomination of representatives in the Pharmacovigilance Risk Assessment Committee (PRAC).
Kind regards,
Roger Obon
Experts and Declarations of Interests Management
Meeting Secretariat Office
Committees and Quality Assurance Department
European Medicines Agency
Domenico Scarlattilaan 6 | 1083 HS Amsterdam | The Netherlands
Telephone +31 (0)88 781 6763
[email protected]<mailto:
[email protected]> | www.ema.europa.eu<https://www.ema.europa.eu/en> | For directions, see How to find us<https://www.ema.europa.eu/en/about-us/contact/how-find-us>
Follow us: [cid:
[email protected]] [cid:
[email protected]] [cid:
[email protected]]
This message and any attachment contain information which may be confidential or otherwise protected from disclosure. It is intended for the addressee(s) only and should not be relied upon as legal advice unless it is otherwise stated. If you are not the intended recipient(s) (or authorised by an addressee who received this message), access to this e-mail, or any disclosure or copying of its contents, or any action taken (or not taken) in reliance on it is unauthorised and may be unlawful. If you have received this e-mail in error, please inform the sender immediately.
P Please consider the environment before printing this e-mail
Classified as confidential by the European Medicines Agency
________________________________________________________________________
This e-mail has been scanned for all known viruses by European Medicines Agency.
________________________________________________________________________
Saatja: Webdesktop <
[email protected]>
Saadetud: 04.03.2021 12:25
Adressaat: SM Info <
[email protected]>; info ravimiamet ee <
[email protected]>;
<
[email protected]>; Elen Ohov <
[email protected]>
Koopia: <
[email protected]>
Teema: Webdesktop: Kiri nr 14-4/254 / Esindajate nimetamine Euroopa Ravimiameti
ravimiohutuse riskihindamise komiteesse (PRAC)
Manused: 254.msg
Tere!
Edastan Euroopa Ravimiameti kirja. Palun andke enne 18.05.2021 EV AEEL-le teada
(
[email protected], cc:
[email protected]), kas me pikendame praeguste liikmete Maia
Uusküla ja Katrin Kiisk mandaati või nimetame uued.
Reg. number: 14-4/254
Reg. kuupäev: 04.03.2021
Sisu: Esindaja nimetamine Euroopa Ravimiameti ravimiohutuse riskihindamise komiteesse
(PRAC); Nomination of representatives in the Pharmacovigilance Risk Assessment
Committee (PRAC) of the European Medicines Agency
Heade soovidega
Tiiu Noobel
[email protected]
sekretär EV AEEL juures
*** TÄHELEPANU *** See e-kiri (kaasa arvatud manused) on mõeldud ainult e-kirja
adressaatidele ning võib sisaldada ametialaseks kasutamiseks ettenähtud teavet. Teavet ei tohi
ilma saatja selgelt väljendatud loata edasi saata ega mistahes viisil kõrvalistele isikutele
avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, palun teavitage sellest
kohe saatjat ning kustutage e-kiri oma arvutist.
*** ATTENTION *** This e-mail and its attachments may contain official information. If
you are not the intended recipient, please notify the sender immediately, delete this e-mail and
destroy any copies. Any dissemination or use of this information by a person other than the
intended recipient is unauthorized and may be unlawful.